BATH & BODY WORKS, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.63B | $12.57B | $12.15B | $11.45B | $10.77B | $10.46B | $10.36B | $9.61B |
| Cost of Revenue | $7.67B | $7.45B | $6.95B | $6.65B | $6.34B | $6.07B | $6.31B | $5.98B |
| Gross Profit | $4.96B | $5.13B | $5.20B | $4.81B | $4.43B | $4.39B | $4.06B | $3.63B |
| Gross Margin | 39.3% | 40.8% | 42.8% | 42.0% | 41.1% | 41.9% | 39.1% | 37.8% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.23B | $3.12B | $3.01B | $2.86B | $2.69B | $2.72B | $2.70B | $2.34B |
| Operating Income | $1.73B | $2.00B | $2.19B | $1.95B | $1.74B | $1.57B | $1.24B | $1.28B |
| Operating Margin | 13.7% | 15.9% | 18.0% | 17.1% | 16.2% | 15.0% | 11.9% | 13.4% |
| Interest Expense | $406.0M | $394.0M | $334.0M | $324.0M | $314.0M | $316.0M | $246.0M | $208.0M |
| Pretax Income | $1.31B | $1.70B | $1.93B | $1.64B | $1.45B | $1.28B | $1.23B | — |
| Income Tax Expense | $329.0M | $538.0M | $681.0M | $594.0M | $543.0M | $528.0M | $377.0M | $446.0M |
| Net Income | $983.0M | $1.16B | $1.25B | $1.04B | $903.0M | $753.0M | $850.0M | $805.0M |
| Net Margin | 7.8% | 9.2% | 10.3% | 9.1% | 8.4% | 7.2% | 8.2% | 8.4% |
| EPS (Basic) | $3.46 | $4.04 | $4.30 | $3.57 | $3.12 | $2.60 | $2.80 | $2.49 |
| EPS (Diluted) | $3.42 | $3.98 | $4.22 | $3.50 | $3.05 | $2.54 | $2.70 | $2.42 |
| Shares Outstanding (Basic) | 284.0M | 287.0M | 291.0M | 292.0M | 290.0M | 290.0M | 304.0M | 323.0M |
| Shares Outstanding (Diluted) | 287.0M | 291.0M | 297.0M | 298.0M | 296.0M | 297.0M | 314.0M | 333.0M |
| Dividends Per Share | $2.40 | $4.40 | $4.00 | $2.36 | $1.20 | $5.00 | $3.80 | $4.60 |